Adam Ang
Also, NSW Health launches its latest virtual menopause health hub in southwestern Sydney.
Proceeds will go to settling debts and focusing on its business in the United States.
The spin-off company is expected to rake in almost $2 billion in revenue this year.
Also, new mobile applications promoting mental wellbeing have been launched.
Also, a Taiwanese startup has received the US FDA's 510(k) clearance for its neurosurgical robot.
Selected early versions will be slated for real-world deployment.
Lyrebird Health plans to scale its operation internationally, beginning in the United Kingdom.
NUS Medicine’s latest model has outperformed DNA-based biological ageing clocks and demonstrated a stronger capability to predict mortality.
What they offer is not a passive but an active clinical assistant that thinks beyond consultation notes.
Also, radiology reporting solutions provider Kailo Medical has acquired a clinician-founded genAI company.